PreveCeutical Medical Inc. (CSE:PREV)
Canada · Delayed Price · Currency is CAD 0.0250
0.00 (0.00%)
Aug 28, 2026, 9:30 AM EST
PreveCeutical Medical Market Cap
PreveCeutical Medical has a market cap or net worth of CAD 15.29 million as of August 28, 2026. Its market cap has decreased by -23.42% in one year.
Market Cap
15.29M
Enterprise Value
20.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since July 14, 2017, PreveCeutical Medical's market cap has increased from 6.06M to 15.29M, an increase of 152.28%. That is a compound annual growth rate of 10.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 15.29M | 2.27% |
| Dec 31, 2025 | 14.95M | 10.43% |
| Dec 31, 2024 | 13.54M | 1.20% |
| Dec 29, 2023 | 13.38M | - |
| Dec 30, 2022 | 13.38M | 4.61% |
| Dec 29, 2021 | 12.79M | -13.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Resverlogix | 32.71M |
| Lobe Sciences | 28.30M |
| Sharp Therapeutics | 27.37M |
| Devonian Health Group | 27.11M |
| Pharmala Biotech Holdings | 25.12M |
| Alzai Health | 24.06M |
| Rapid Dose Therapeutics | 16.37M |
| Hemostemix | 15.83M |